Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 9,530 shares at $15.03 ($143K) on 2006-12-18, disclosed to the SEC on 2006-12-20.
Scheduled sale ($143k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.03 | 1,502 | $23K | 15.8% |
| 2 | $15.00 | 4,713 | $71K | 49.4% |
| 3 | $15.00 | 3,315 | $50K | 34.8% |
| Total | $15.00 avg | 9,530 | $143K | 100% |
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |